Skip to contentClarengateINTELLIGENCE
Companies/12189448

Crispr Biotech Engineering Ltd

Company profile

DissolvedUnited Kingdom
Register Ask analyst

Financial position

Accounts to 2025-09-30 · GBP · Company accounts

Net assets
−£36,842
Cash
—
Turnover
—
Profit / loss
—
Current assets
−£36,842
Creditors < 1 year
—
Equity
−£36,842
Average employees
0

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

6 periods
Reported figures2025-09-30Company2024-09-30Company2023-09-30Company2022-09-302021-09-302020-09-30
Balance sheet
Net assets−£36,842−£36,842−£36,624−£37,075−£36,624−£6,479
Equity−£36,842−£36,842−£36,624−£37,075−£36,624−£6,479
Assets
Current assets−£36,842−£19,704−£22,067−£8,113£1,515£1,571
Liabilities
Creditors within one year—£17,138£14,557£28,362£9,045£149
Creditors after one year————£28,494£7,901
Net current assets−£36,842−£36,842−£36,624−£36,475−£7,530£1,422
Assets less current liabilities−£36,842−£36,842−£36,624—−£7,530£1,422
People
Average employees000011
Source evidenceView filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Register status requires review: Dissolved.
Show 1 satisfied / released
All Assets · created 2021-03-11 · satisfied 2025-10-28
—
Satisfied